Back to Clinical Pharmacology & PK
Clinical Pharmacology & PKv2020Evidence-Based

Vancomycin AUC-Guided Dosing

AUC-guided vancomycin dosing check via the two-concentration method: elimination rate constant Ke from two timed levels, clearance from Ke × Vd (0.7 L/kg), then AUC24 = total daily dose / clearance. Target AUC24 400-600 mg·h/L (AUC/MIC 400-600) per the 2020 vancomycin guidelines.

Clinical Input Parameters

kg
Range: 20 — 300 kg
mg
Range: 250 — 4000 mg
hours
Range: 6 — 72 hours
mg/L
Range: 1 — 100 mg/L
hours
Range: 0 — 72 hours
mg/L
Range: 1 — 100 mg/L
hours
Range: 0 — 72 hours
mg/L
Range: 0.125 — 8 mg/L
Clinical Assessment
Awaiting Parameters
auc mic
—ratio
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Vancomycin AUC-Guided Dosing is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within clinical pharmacology & pk.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Ke = ln(C1/C2)/(t2-t1); CL = Ke * 0.7 * weight_kg; AUC24 = (dose_mg * 24/interval_h) / CL

Clinical Pearls & Practice Notes

  • Category mapped from curated 'drug dosing' to 'infectious_disease' (vancomycin therapeutic drug monitoring context).
  • Assumes steady state and that both levels were drawn in the elimination phase (after distribution).
  • Uses population Vd 0.7 L/kg; individual Vd varies — treat as an estimate and confirm with clinical response.
  • Target AUC/MIC 400-600 assumes the reported MIC; if MIC >1, target attainment requires proportionally higher AUC.

Evidence & Literature Citations

  1. Rybak MJ, Le J, Lodise TP, et al. Therapeutic monitoring of vancomycin for serious MRSA infections: a revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. Am J Health-Syst Pharm. 2020;77(11):835-864. (AUC/MIC 400-600 target)

Score Interpretation Ranges

Below target0 – 399.9 pts

AUC below target

In target400 – 600 pts

AUC in target range

Above target600.1 – 10000 pts

AUC above target

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.